Understanding the Immune System's Response to Breast Cancer in Young Women

This observational study aims to understand how the immune system responds to breast cancer in young women. Researchers will look at how much the immune system is suppressed in different types of breast cancer, including those related to pregnancy (Pregnancy Associated Breast Cancer or PABC). They will use blood, urine, and tissue samples to compare PABC with non-PABC cases, and also compare different types of breast cancer. This research will help scientists better understand how breast cancer works and could lead to new treatments in the future. You may be able to join if you are a woman over 18 with a confirmed breast cancer diagnosis and have tissue samples available. The main goal is to see how long people live without their cancer getting worse (Progression Free Survival) throughout the study.

Study design
This is an observational study, meaning researchers will collect information without giving any specific treatments. It plans to enroll 800 women.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will track how long participants live without their cancer getting worse (Progression Free Survival) throughout their participation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT01503190

The Immune System's Response to Young Women's Breast Cancer

Recruiting
Not specifiedAges 18+Observational
University of Colorado, Denver
~800 participants
Updated 2026-01-29 on ClinicalTrials.gov

At a glance

Recruiting sites
5 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Progression Free Survival
Measured over Throughout study participation
Breast Cancer
Breast Cancer and Pregnancy
5 sites across 1 states
Colorado5
  • Virginia Borges, MD, MMSc · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver

Opens a ready-to-send draft in your own email app — review before sending.

  • Progression Free SurvivalThroughout study participation

    Prospective cohort study.